Massberg, Steffen <br/><br/>
Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting.  [electronic resource] 

 -  American heart journal  Nov 2003 
 - E19 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/S0002-8703(03)00368-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--therapeutic use<br/>Aspirin--administration & dosage<br/>Blood Platelets--metabolism<br/>Clopidogrel<br/>Coronary Disease--blood<br/>Drug Therapy, Combination<br/>Endothelium, Vascular--metabolism<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Male<br/>Middle Aged<br/>P-Selectin--metabolism<br/>Platelet Activation--drug effects<br/>Platelet Aggregation--drug effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Prospective Studies<br/>Stents<br/>Ticlopidine--administration & dosage<br/>Tirofiban<br/>Tyrosine--analogs & derivatives